Analysts Estimate Danaher (DHR) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 04/18/23
Danaher Announces Conversion Date for Series B Mandatory Convertible Preferred StockPRNewsWire • 04/10/23
2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to WatchThe Motley Fool • 03/25/23
Capitalizing On Chaos: My Aggressive Move To Buy More Of These 5 Dividend Growth WondersSeeking Alpha • 03/21/23
Danaher Partners with the University of Pennsylvania's Center for Cellular Immunotherapies to Address Manufacturing Challenges Impacting the Uptake of Cell TherapiesPRNewsWire • 03/07/23
The Dividend Pyramid: Potentially Beat The Market With This 12-Stock PortfolioSeeking Alpha • 03/03/23